Health Care Equipment

CUE HEALTH INC

AMPLITECH GROUP INC. COM USD0.001 (S/R 18/07/2026)

Akanda

Netcapital

AMPLITECH GROUP INC. USD0.001 S/R 20/11/26 SER B

Agape ATP

Co-Diagnostics

NewGenIvf

Tradr 2X Long QBTS Daily ETF

Tradr 2X Long RGTI Daily ETF

Defiance Daily Target 2X Long RGTI ETF

The Global Luminex Multiplex Assays Market is projected to grow from USD 1.82 billion in 2025 to USD 3.89 billion by 2033, at a CAGR of 10.0%. This growth is driven by the rising demand for high-throughput biomarker profiling and standardized testing workflows. Key factors include the efficiency of multiplex systems, regulatory support for standardized panels, and the expansion of outsourced research models. However, challenges such as validation complexity and elevated costs may impact adoption rates.

fidelity

Luminex Multiplex Assays Market Projected to Reach USD 3.89 Billion by 2033, Driven by Rising Demand for High-Throughput Biomarker Profiling and Standardized Multiplex Testing Workflows: Verified Market Research

Chinese rehabilitation robot manufacturers are expanding into international markets, leveraging technological advancements despite facing regulatory challenges. Experts highlight the rapid development of robot technology and the importance of partnerships for market entry. The global rehabilitation equipment market is projected to grow significantly, driven by an aging population and increasing health issues. Companies are adapting their strategies to meet varying market receptiveness, particularly in Europe and the U.S.

Yicai

Chinese Rehab Robot Makers Leverage Tech Advantages to Expand Overseas, Experts Say

HLTHQ

CTKB

SBIO

A prominent gastrointestinal molecular diagnostics company, Cyted Health, has revealed on April 16, 2026, that they are currently conducting a clinical validation study at various locations in the United States. The company, headquartered in WILMINGTON, Del., and CAMBRIDGE, England, shared that their laboratory in the US has successfully accomplished this milestone. The study spans across multiple sites and is aimed at validating their technology and methods. This news signifies a significant step for Cyted Health as they work towards further establishing their presence in the field.

Unusual Whales

Cytek Biosciences

iShares Biotechnology ETF

ALPS Medical Breakthrough

VanEck Biotech ETF

SPDR S&P Biotech

iShares US Medical Devices

Direxion S&P Biotech Bull 3X

SPDR S&P Health Equip

Invesco Biotechnology & Genome ETF

Proshares Ultra Nasdaq Biotech

First Trust NYSE Arca Biotech Index Fd

Cyted Health's US Laboratory Achieves College of American Pathologists Accreditation

Teal Health's report "State of Her Health 2026" reveals that 75% of women are avoiding healthcare due to time constraints, lack of access, and outdated systems. The findings emphasize the pressing need for improvements in the healthcare sector to better address women's specific needs and ensure they receive necessary health services.

Universal Health Realty Income

Eheatlh

75% of women are skipping healthcare due to time constraints and outdated systems - Teal Health's Report State of Her Health 2026.

Curitics Health Solutions has launched its Winter Release, featuring AI-driven innovations aimed at modernizing care delivery and reducing administrative burdens. Key enhancements include new MLTSS and Prior Authorization modules, expanded Generative AI capabilities, AI-aided care planning, and ambient clinical documentation tools. The release aims to improve decision-making and streamline workflows for healthcare organizations, ultimately enhancing care quality and reducing clinician burnout. Curitics Point of Care, an EMR-integrated provider experience, is also introduced to support real-time decision-making and reduce context switching for providers.

prnewswire

VG Health

Streamline Health Solutions

Option Care Health

Health Care Select Sector SPDR

SPDR S&P Health

13:38 ET
			
			
				Curitics Health Solutions Unveils Winter Release: New AI-Driven Innovations to Streamline Care Delivery and Reduce Administrative Burden

HRTS

Jefferson Health and Qualified Health have announced a collaboration to develop and deploy generative AI across Jefferson's multi-state network. This partnership aims to enhance patient care and clinician support through innovative AI solutions, focusing on quality registry solutions and automating administrative tasks. The initiative emphasizes a coordinated, enterprise-wide approach to AI integration, ensuring governance and clinician trust. Qualified Health will provide training and performance monitoring to drive improvements in care quality and operational efficiency. Jefferson Health is committed to evolving care delivery through responsible AI integration.

Jefferson Capital

Performant Healthcare

Tema Cardiovascular And Metabolic ETF

12:30 ET
			
			
				Jefferson Health Deepens AI Capabilities Through Collaboration With Qualified Health

AGIX

Qualified Health and Anthropic have launched an AI deployment at the University of Texas System to enhance access to evidence-based healthcare. The AI system analyzes millions of medical records to identify patients eligible for guideline-recommended care, addressing the challenge of timely clinical review. Initial deployment focuses on cardiology, with plans to expand to other specialties by 2026. The initiative aims to close care gaps for millions of Texans, ensuring that patients receive appropriate evaluations and treatments, ultimately improving healthcare outcomes across the state.

KraneShares Artfcl Intllgnc and Tech ETF

13:54 ET
			
			
				Qualified Health and Anthropic Launch Landmark AI Deployment at University of Texas Institutions to Expand Access to Life-Saving, Evidence-Based Care for Millions of Texans

The global home care testing market is projected to reach USD 17.95 billion by 2030, growing at a CAGR of 9.36% from 2025. This growth is driven by increasing demand for accessible healthcare, advancements in diagnostic technologies, and the need for cost-effective solutions. Key developments include Cue Health's launch of at-home diagnostic tests and Lucira Health's FDA-authorized flu and COVID-19 test. The geriatric segment leads the market, with urine samples and infectious disease tests dominating. North America holds the largest market share due to its healthcare infrastructure and aging population.

GlobeNewswire

CABBEEN

REACH

Cue BioPharma

KeyCorp

KINDSTAR GLOBAL

Carter Bankshares

Revolutionizing At-Home Healthcare: Home Care Testing Market Insights and Forecasts to 2030

CUE HEALTH INC(HLTHQ.US)

Luminex Multiplex Assays Market Projected to Reach USD 3.89 Billion by 2033, Driven by Rising Demand for High-Throughput Biomarker Profiling and Standardized Multiplex Testing Workflows: Verified Market Research

Chinese Rehab Robot Makers Leverage Tech Advantages to Expand Overseas, Experts Say

Cyted Health's US Laboratory Achieves College of American Pathologists Accreditation

75% of women are skipping healthcare due to time constraints and outdated systems - Teal Health's Report State of Her Health 2026.

13:38 ET Curitics Health Solutions Unveils Winter Release: New AI-Driven Innovations to Streamline Care Delivery and Reduce Administrative Burden

12:30 ET Jefferson Health Deepens AI Capabilities Through Collaboration With Qualified Health

13:54 ET Qualified Health and Anthropic Launch Landmark AI Deployment at University of Texas Institutions to Expand Access to Life-Saving, Evidence-Based Care for Millions of Texans

Revolutionizing At-Home Healthcare: Home Care Testing Market Insights and Forecasts to 2030